News

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer. 

Congress Money washington DC legislation coverage payment

Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.

heart surgery cardiac surgeons

There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.

FDA recall medical device recall product recall

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

Prenuvo MRI

Sean Clifford filed the lawsuit Sept. 24, 2024, in the New York State Supreme Court, contending a radiologist failed to spot signs of a forthcoming stroke.   

insurance insurer payment claim denial reimbursement prior authorization

This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology. 

IV hospital room intravenous drip solution

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

healthcare surprise billing statement payment

A new analysis claims the “benchmark” qualifying payment amount insurers calculate often “dramatically” understates the actual median in-network rates they are paying for in-network care.  

By reducing report variability, the software could help decrease unnecessary biopsies in patients with questionable lesions.

Advanced device-based therapies are associated with significant benefits for heart failure patients and should be used alongside traditional pharmaceutical treatments, according to a new scientific statement from the Heart Failure Society of America (HFSA). The statement, published in full in the Journal of Cardiac Failure, examines a number of new-look medical devices that have emerged in recent years as additional ways to treat heart failure.

Device-based therapies can provide considerable value for heart failure patients when used alongside traditional pharmaceutical treatments. A new HFSA scientific statement outlines the benefits of these devices, urging care teams to implement them into daily practice. 

The impending shortage pertains to molybdenum-99, or Mo-99. A structural issue has occurred with a pipe within the high-flux reactor in Petten, Netherlands, which will require an immediate repair. 

Thumbnail

"We are failing to rescue women after high-risk surgery," one researcher said after reviewing years of Medicare data. 

Around the web

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.